Where does your data go when you use Global Relay’s AI-enabled surveillance?
We’ve mapped how your data moves through our closed ecosystem for analysis by our AI-enabled surveillance solution, and what safety measures we’re taking to ensure your data is never compromised.
FDA takes aim at pharmaceuticals’ social media activity
The FDA is turning its eye towards pharmaceuticals’ social media use. Review the laws and regulations triggering FDA warning letters and how to stay compliant.
How a people-first plan ensures effective data governance in the age of AI
Life sciences companies are keen to utilize cutting-edge AI tools and software, but data governance programs need to be in top form first.
Four key challenges for compliant mobile communications in healthcare and life sciences
Compliance teams in healthcare and life sciences must balance both regulatory restrictions and the needs of employees to achieve compliant mobile communications with corporate devices.
Data structure and enrichment is key to unlocking the full potential of AI-powered surveillance
More than two-thirds of compliance teams have or are considering implementing AI tools. Learn how the clear, content-rich format of Unified Parsed Messages boosts the speed and accuracy of AI-powered surveillance.
ACER shows suspicious transaction reports are rising across EU energy markets under new REMIT
The first-of-its-kind assessment looks at how regulators are processing reports of potential financial misconduct within wholesale energy markets and offers suggestions for PPATs to improve reporting amidst increased regulatory scrutiny.